Incruse ellipta and Klor-con drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Incruse ellipta (umeclidinium bromide) and Klor-con (potassium chloride). Common drug interactions include restless legs syndrome among females and acute respiratory failure among males.

The phase IV clinical study analyzes what interactions people have when they take Incruse ellipta and Klor-con. It is created by eHealthMe based on reports of 45 people who take the same drugs from the FDA, and is updated regularly.

What is Incruse ellipta?

Incruse ellipta has active ingredients of umeclidinium bromide. eHealthMe is studying from 8,485 Incruse ellipta users. Check the latest studies of Incruse ellipta.

What is Klor-con?

Klor-con has active ingredients of potassium chloride. It is often used in hypokalemia. eHealthMe is studying from 27,547 Klor-con users. Check the latest studies of Klor-con.

On Jul, 27, 2026

45 people who take Incruse ellipta and Klor-con together, and have interactions are studied.

Incruse ellipta and Klor-con drug interactions.

What are the common drug interactions of Incruse Ellipta and Klor-Con, by gender? *:

female:

Restless legs syndrome (a powerful urge to move your legs)
Sepsis (a severe blood infection that can lead to organ failure and death)
Syncope (loss of consciousness with an inability to maintain postural tone)
Tooth extraction
Upper-airway cough syndrome
Vision blurred
Visual impairment
Weight decreased
Weight increased
Wheezing (a high-pitched whistling sound made while you breath)

male:

Acute respiratory failure
Anaemia (lack of blood)
Septic shock (shock due to blood infection)
Asthma
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Cluster headache (one-sided head pain with tearing)
Coronary arterial stent insertion
Cough
Diarrhoea
Gastrointestinal disorder (functional problems of gastrointestinal tract)

What are the common drug interactions of Incruse Ellipta and Klor-Con, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Chronic kidney disease
Emotional distress
Pain
Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
Renal failure (kidney dysfunction)
Tooth extraction

60+:

Renal failure (kidney dysfunction)
Chronic kidney disease
Pneumonia pseudomonal (pseudomonas pneumonia is an infection caused by the microbe known as pseudomonas aeruginosa)
Renal injury (kidney injury)
Septic shock (shock due to blood infection)
Dyspnoea (difficult or laboured respiration)
Fall
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Arthralgia (joint pain)
Balance disorder

What are the existing conditions these people have? *

Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 7 people, 15.56%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 7 people, 15.56%
High Blood Pressure: 6 people, 13.33%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 13.33%
High Blood Cholesterol: 5 people, 11.11%
Migraine (headache): 5 people, 11.11%
Hypersensitivity: 4 people, 8.89%
Immunodeficiency Common Variable: 4 people, 8.89%
Asthma: 4 people, 8.89%
Gout (uric acid crystals building up in the body): 4 people, 8.89%

* Approximation only. Some reports may have incomplete information.

Do you take Incruse ellipta and Klor-con?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously